+467.0%
MRNA vs UVXY
-66.8%
+533.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | UVXY | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -6.8% | +12.2% | +3.1% |
| 7D | -1.1% | +2.8% | -3.9% | +0.1% |
| 30D | +126.1% | -11.4% | +137.5% | +120.1% |
| 3M | +190.0% | -41.5% | +231.5% | +158.5% |
| 6M | +157.2% | -61.0% | +218.3% | +115.7% |
| YTD | +388.2% | -49.8% | +438.0% | +338.5% |
| 1Y | +467.0% | -66.4% | +533.5% | +388.9% |
| All | +467.0% | -66.8% | +533.9% | +388.9% |
Cumulative growth
Daily Returns
Daily percentage return beside UVXY.
Daily Out/Under-Performance
Portfolio return minus UVXY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × UVXY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded UVXY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling